iUTMB Home Page iUTMB    Published Thursday, August 9, 2012, 7:00 AM

Building a better Rift Valley fever vaccine

Guidry News

The Rift Valley fever virus usually affects livestock, causing abortions and deaths in newborn animals, but it can also be passed to humans (zoonosis). An experimental vaccine is in development — a live attenuated strain of the virus, known as MP-12 — but this has not completed early clinical trials, partly because of concerns that it could still cause disease (virulence). Researchers from UTMB are developing an improved version that could make an impact against this growing disease. Coverage also appears in Science Daily, FierceVaccines.comGalvmed, BioPortfolio, HighBeam Research,  Biotech Mashup and WittySparks.


Original UTMB News Release


  • President's Report

    President's Report

  • Impact Online Newsletter

    Impact Online Newsletter

  • Transforming Health Care

    Transforming Health Care

  • Medicaid 1115 Waiver

    Medicaid 1115 Waiver

  • Working Together Fact Sheet

    Working Together Fact Sheet

  • Health System Friday Focus

    Health System Friday Focus

  • Fourth Friday Focus

    Fourth Friday Focus

  • Business & Finance Quarterly

    Business & Finance Quarterly

  • The Road Ahead

    The Road Ahead

  • UTMB Scorecard

    UTMB Scorecard

  • UTMB Magazine Archive

    UTMB Magazine Archive